INGN
Price
$10.47
Change
-$0.05 (-0.48%)
Updated
Jan 17 closing price
Capitalization
176.12M
37 days until earnings call
ZTEK
Price
$1.18
Change
+$0.20 (+20.41%)
Updated
Jan 17 closing price
Capitalization
120.63M
Ad is loading...

INGN vs ZTEK

Header iconINGN vs ZTEK Comparison
Open Charts INGN vs ZTEKBanner chart's image
Inogen
Price$10.47
Change-$0.05 (-0.48%)
Volume$149.53K
Capitalization176.12M
Zentek
Price$1.18
Change+$0.20 (+20.41%)
Volume$213.75K
Capitalization120.63M
INGN vs ZTEK Comparison Chart
Loading...
INGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INGN vs. ZTEK commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INGN is a Hold and ZTEK is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (INGN: $10.47 vs. ZTEK: $1.18)
Brand notoriety: INGN and ZTEK are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: INGN: 83% vs. ZTEK: 354%
Market capitalization -- INGN: $176.12M vs. ZTEK: $120.63M
INGN [@Medical Specialties] is valued at $176.12M. ZTEK’s [@Medical Specialties] market capitalization is $120.63M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INGN’s FA Score shows that 0 FA rating(s) are green whileZTEK’s FA Score has 0 green FA rating(s).

  • INGN’s FA Score: 0 green, 5 red.
  • ZTEK’s FA Score: 0 green, 5 red.
According to our system of comparison, INGN is a better buy in the long-term than ZTEK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INGN’s TA Score shows that 5 TA indicator(s) are bullish while ZTEK’s TA Score has 6 bullish TA indicator(s).

  • INGN’s TA Score: 5 bullish, 4 bearish.
  • ZTEK’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ZTEK is a better buy in the short-term than INGN.

Price Growth

INGN (@Medical Specialties) experienced а +9.63% price change this week, while ZTEK (@Medical Specialties) price change was +12.91% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

INGN is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INGN($176M) has a higher market cap than ZTEK($121M). ZTEK YTD gains are higher at: 25.521 vs. INGN (14.177). ZTEK has higher annual earnings (EBITDA): -11.39M vs. INGN (-58.34M). INGN has more cash in the bank: 128M vs. ZTEK (5.35M). ZTEK has less debt than INGN: ZTEK (1.28M) vs INGN (21.9M). INGN has higher revenues than ZTEK: INGN (316M) vs ZTEK (48.6K).
INGNZTEKINGN / ZTEK
Capitalization176M121M145%
EBITDA-58.34M-11.39M512%
Gain YTD14.17725.52156%
P/E Ratio71.43N/A-
Revenue316M48.6K650,206%
Total Cash128M5.35M2,394%
Total Debt21.9M1.28M1,716%
FUNDAMENTALS RATINGS
INGN vs ZTEK: Fundamental Ratings
INGN
ZTEK
OUTLOOK RATING
1..100
2568
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
10077
SMR RATING
1..100
9597
PRICE GROWTH RATING
1..100
3847
P/E GROWTH RATING
1..100
65100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZTEK's Valuation (71) in the null industry is in the same range as INGN (80) in the Medical Specialties industry. This means that ZTEK’s stock grew similarly to INGN’s over the last 12 months.

ZTEK's Profit vs Risk Rating (77) in the null industry is in the same range as INGN (100) in the Medical Specialties industry. This means that ZTEK’s stock grew similarly to INGN’s over the last 12 months.

INGN's SMR Rating (95) in the Medical Specialties industry is in the same range as ZTEK (97) in the null industry. This means that INGN’s stock grew similarly to ZTEK’s over the last 12 months.

INGN's Price Growth Rating (38) in the Medical Specialties industry is in the same range as ZTEK (47) in the null industry. This means that INGN’s stock grew similarly to ZTEK’s over the last 12 months.

INGN's P/E Growth Rating (65) in the Medical Specialties industry is somewhat better than the same rating for ZTEK (100) in the null industry. This means that INGN’s stock grew somewhat faster than ZTEK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INGNZTEK
RSI
ODDS (%)
Bullish Trend 11 days ago
77%
Bullish Trend 11 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
83%
Bearish Trend 11 days ago
87%
Momentum
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 11 days ago
79%
MACD
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 11 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
75%
Bullish Trend 11 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
75%
Bearish Trend 11 days ago
88%
Advances
ODDS (%)
Bullish Trend 16 days ago
72%
Bullish Trend 13 days ago
79%
Declines
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 11 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
80%
N/A
Aroon
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 11 days ago
87%
View a ticker or compare two or three
Ad is loading...
INGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CZMWY49.681.94
+4.06%
Carl Zeiss Meditec AG
BYDDY68.091.34
+2.01%
BYD Co., Ltd.
ANLDF0.06N/A
+1.96%
Anfield Energy Inc.
HNNMY2.660.04
+1.53%
Hennes & Mauritz AB
BIREF3.950.05
+1.28%
Birchcliff Energy Ltd.

INGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, INGN has been loosely correlated with VCYT. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INGN jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INGN
1D Price
Change %
INGN100%
-0.48%
VCYT - INGN
41%
Loosely correlated
-1.27%
MYGN - INGN
34%
Loosely correlated
-1.04%
SHC - INGN
34%
Loosely correlated
+2.29%
AVNS - INGN
33%
Poorly correlated
-0.81%
ALC - INGN
31%
Poorly correlated
+0.27%
More

ZTEK and

Correlation & Price change

A.I.dvisor tells us that ZTEK and TLTFF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZTEK and TLTFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTEK
1D Price
Change %
ZTEK100%
+20.40%
TLTFF - ZTEK
27%
Poorly correlated
+2.92%
VERO - ZTEK
25%
Poorly correlated
-1.97%
RVTY - ZTEK
25%
Poorly correlated
-0.90%
NVNO - ZTEK
25%
Poorly correlated
+3.46%
INGN - ZTEK
23%
Poorly correlated
-0.48%
More